DAE HWA Pharmaceutical Market Cap

DAE HWA Pharmaceutical has a market cap or net worth of 250.31 billion as of March 6, 2026. Its market cap has increased by 39.82% in one year.

Market Cap

250.31B

Enterprise Value

347.65B

Revenue

149.47B

Ranking

n/a

PE Ratio

6,300.92

Stock Price

14,290.00

Market Cap Chart

Since March 1, 2004, DAE HWA Pharmaceutical's market cap has increased from 15.67B to 250.31B, an increase of 1,497.59%. That is a compound annual growth rate of 13.41%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	250.31B	-18.01%
Dec 30, 2025	305.32B	59.32%
Dec 30, 2024	191.63B	16.63%
Dec 28, 2023	164.31B	-0.21%
Dec 29, 2022	164.66B	0.86%
Dec 30, 2021	163.26B	-39.51%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
NOVAREX	224.64B
Vivozon Pharmaceutical	198.94B
OPTUS Pharmaceutical	191.47B
CellBion	336.19B
GREEN CROSS WellBeing	168.58B
Organoidsciences	158.72B
High Tech Pharm	147.27B
Kyung Dong Pharmaceutical	142.52B

Market Cap Rankings